Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal stem cells and fibroblast cells on amniotic membranes for chronic wound healing
IRCT20090128001605N17Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2015
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of mesenchymal stem cells in Chronic wound (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Percentage of wound healing and Duration of wound healing. Started Apr 2015; status: completed.
02
Drugs
mesenchymal stem cells
03
Conditions
Chronic wound
Beyond the preview
Go deeper on IRCT20090128001605N17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090128001605N17.